Abbott India

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE358A01014
NSEID: ABBOTINDIA
BSEID: 500488
View on NSE | View on BSE

INR

27,800.00

245 (0.89%)

BSENSE

Jul 31, 03:41 PM

BSE+NSE Vol: 6.62 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ipca Labs

Ajanta Pharma

Gland Pharma

Biocon

Glenmark Pharma

Aurobindo Pharma

Anthem Bioscienc

Alkem Lab

Abbott India

Glaxosmi. Pharma

Dr Reddy's Labs

Why is Abbott India Ltd. ?

Flat results in Mar 26

ROCE(HY) Lowest at 42.54%

With ROE of 32.5, it has a Very Expensive valuation with a 12.3 Price to Book Value

The stock is trading at a fair value compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -19.20%, its profits have risen by 9.7% ; the PEG ratio of the company is 3.9

Underperformed the market in the last 1 year

Even though the market (BSE500) has generated returns of 1.95% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -19.20% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Abbott India for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Abbott India

-19.2%

-0.95

20.27%

Sensex

-3.81%

-0.28

13.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.96%

EBIT Growth (5y)

16.04%

EBIT to Interest (avg)

90.03

Debt to EBITDA (avg)

0.10

Net Debt to Equity (avg)

-0.44

Sales to Capital Employed (avg)

1.63

Tax Ratio

25.36%

Dividend Payout Ratio

71.36%

Pledged Shares

Institutional Holding

9.16%

ROCE (avg)

137.96%

ROE (avg)

31.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

12.28

EV to EBIT

31.13

EV to EBITDA

29.88

EV to Capital Employed

21.01

EV to Sales

8.16

PEG Ratio

3.88

Dividend Yield

2.38%

ROCE (Latest)

67.48%

ROE (Latest)

32.51%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 2,254.95 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 19.16 times

-2What is not working for the Company

ROCE(HY)

Lowest at 42.54%

Loading Valuation Snapshot...

Here's what is working for Abbott India

Cash and Cash Equivalents - Half Yearly

Highest at Rs 2,254.95 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly

Highest at 19.16 times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio